22 results
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
Doses of Antituberculosis ... and Children - IDSA ... #Medications #management ... #pharmacology # ... Table
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... Tuberculosis #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 4/11/2020 #Drugs ... #COVID19 #Pharmacology ... #Table #Management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... be considered (doses ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
Oral Antibiotics for Acne - Indicated for Moderate-to-Severe Acne 
First-Line Drug Class: Tetracyclines 

In the last
Acne First-Line Drug ... reviewed mild acne treatment ... can also pulse-dose ... #Pharmacology # ... Management #Dermatology
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
nephrotoxic agents, the dose ... • Treatment includes ... prevention by minimizing ... Vancomycin #AKI #pharmacology ... toxicology #diagnosis #management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... p-Aminosalicylic acid, High-dose ... Tuberculosis #MDRTB #management ... #regimens #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... (Varivax™), 2 doses ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology